| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNIBAS000006497 |
|
|
Titolo |
Chimica del suolo / coordinatore Paolo Sequi ; testi di: Enza Arduino ... [et al.] |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Bologna : Pàtron Editore, 1989 |
|
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Collana |
|
Scienza e tecniche delle produzioni vegetali |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Terreno agrario - Analisi chimica |
Pedologia |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
2. |
Record Nr. |
UNINA9910790079203321 |
|
|
Autore |
Zivin Justin A |
|
|
Titolo |
tPA for stroke [[electronic resource] ] : the story of a controversial drug / / Justin A. Zivin, John Galbraith Simmons |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
New York, : Oxford University Press, 2011 |
|
|
|
|
|
|
|
ISBN |
|
1-283-12126-3 |
9786613121264 |
0-19-978094-3 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (206 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Cerebrovascular disease - Chemotherapy - History |
Tissue plasminogen activator - Therapeutic use - History |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Code stroke on Market street -- Clot-buster : the natural history -- Dead or alive -- Brain-O -- The brain doctors cometh : slowly -- What |
|
|
|
|
|
|
|
|
|
|
|
emergency? -- Money and brains -- Deer in the headlights -- Call 911, 112, 15 ... even 999 -- Persistence of a most controversial drug -- Through the looking glass -- Post-script. |
|
|
|
|
|
|
Sommario/riassunto |
|
Without warning stroke can paralyze, blind, or kill. Some victims recover, but many do not and may even suffer another disabling or fatal attack. The drug known as tPA can drastically reduce the long-term disability associated with stroke, but despite its near-miraculous capabilities and the growing support of most neurologists, it has been slow to win acceptance as the standard of care in emergency departments nationwide. tPA for Stroke chronicles how this remarkable drug came to be tested in stroke victims, its early years in development by the pharmaceutical giant Genentech, and its eventua |
|
|
|
|
|
|
|
| |